If the preference for absolute freedom over the free person is a fact of the sexual revolution, the present time is as much ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
In an exclusive interview, Trish Karlin of the Elizabeth Glaser Pediatric AIDS Foundation discusses the impact of $32.7m ...
The CDC budget cuts could pose headwinds for HIV drugmakers like Gilead and Merck but are unlikely to severely cripple their ...
The results of a groundbreaking trial carried out in Durban to find a cure for HIV are showing promise, scientists say.
The Department of Health and Human Services (HHS) is reportedly poised to slash funding for domestic HIV prevention at the ...
Priscilla Tsondai, MD, MPH, breaks down top care gaps as opportunities for care improvement.
A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...